David Fuks
David Fuks publishes mostly in Surgery, Hepatology and Oncology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Pancreatic and Hepatic Oncology Research.
- World rank
- #463,585 of 7,710,434 ranked researchers
- Rank in France
- #24,592 of 324,115
- Works
- 571
- Citations
- 14k
- Citations per work
- 23.9
What does David Fuks research?
David Fuks's work is mostly in Medicine (85%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences48484.8%
- Medicine48484.8%
- Everything else8715.2%
- 1Surgery32% of their works
- 2Hepatology17% of their works
- 3Oncology16% of their works
- 4Pulmonary and Respiratory Medicine14% of their works
- 5Epidemiology4% of their works
- 6Radiology, Nuclear Medicine and Imaging2% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Organ Transplantation Techniques and Outcomes
- Colorectal Cancer Surgical Treatments
- Gastric Cancer Management and Outcomes
- Liver Disease Diagnosis and Treatment
Which keywords describe David Fuks's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Cancer, Management, Neoadjuvant Therapy, Chemotherapy and Biliary Tract Cancer.
- NAFLD
- Endoscopic Resection
- Preoperative Chemoradiotherapy
- Ischemia-Reperfusion Injury
- Cholecystitis
- Pancreatic Cancer
- Biliary Tract Cancer
- Neoadjuvant Therapy
- Liver Cancer
- Hepatocellular Carcinoma
- Clinical Practice Guidelines
- Cholangiocarcinoma
- Management
- Chemotherapy
- Intrahepatic Cholangiocarcinoma
- Surgical Complications
- ERCP
- Liver Transplantation
- Rectal Cancer
- Gastric Cancer
- NASH
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Practice Guidelines3473 topics
- Hepatocellular Carcinoma2722 topics
- Cholangiocarcinoma2492 topics
- Liver Cancer2341 topic
- Management2341 topic
- Neoadjuvant Therapy1882 topics
- Chemotherapy1812 topics
- Biliary Tract Cancer1401 topic
- Intrahepatic Cholangiocarcinoma1401 topic
- Pancreatic Cancer1281 topic
- Surgical Complications1281 topic
- Cholecystitis1091 topic
- ERCP1091 topic
- Ischemia-Reperfusion Injury671 topic
- Liver Transplantation671 topic
- Preoperative Chemoradiotherapy601 topic
- Rectal Cancer601 topic
- Endoscopic Resection531 topic
- Gastric Cancer531 topic
- NAFLD381 topic
- NASH381 topic
Where does David Fuks work?
David Fuks's main affiliation in the publication record is Institute Mutualiste Montsouris, France.
How many publications and citations does David Fuks have?
OpenAlex counts 571 works and 13,643 citations for David Fuks, an h-index of 61, ranking #463,585 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named David Fuks
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Fuks. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.